Toggle navigation
HOME
NEWSFEEDS
Healthcare Industry News
Medical Devices
Biopharmaceuticals
Diagnostics
Cardiology
Interventional
Neuro
Oncology
Orthopaedic
Surgery
People
Distribution
FDA Actions
Regulatory (INTL)
Mergers & Acquisitions
Venture Capital
INDEPENDENT REPS
For MANUFACTURERS:
Find Reps NOW
Post Your Rep Opportunity
Not sure? Let us help!
For REPS and DISTRIBUTORS:
Not in FindReps? Contact us!
ISR REGISTRY:
Independent Sales Reps - USA
Not a MEMBER Yet?
Join HSMN
FORUMS
Independent Sales Reps & Distributors
The Network Bulletin Board
Getting Started in Medical Sales
Show All Forums
RESOURCES
FindReps®
Help / FAQs
INDUSTRY LINKS:
Medical Device Companies
Biopharmaceutical Companies
Professional Organizations
Government & Regulatory
Products & Services
Venture Capital
MEMBERS
Join HSMN
Forgot Username / Password
Help / FAQs
PASSWORD REQUIRED:
Company Links Listing (Manufacturers)
Products & Services Listing (Vendors)
Post in Forums
Renew Membership
Change Password
Update Contact Info
Something else? - Contact Us
ABOUT
About HSMN
Membership Info
FindReps®
Join HSMN
Help / FAQs
Submit News Release
Info for Advertisers
Contact Us
Searching News Database:
Bilastine
HSMN NewsFeed - 10 Aug 2018
Nuvo Pharmaceuticals(TM) Announces Letter of Intent to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals
Biopharmaceuticals
Acquisitions
HSMN NewsFeed - 19 Dec 2016
Aralez Announces Commercial Launch Of BLEXTEN(TM) In Canada
Biopharmaceuticals
Product Launch
HSMN NewsFeed - 25 Apr 2016
Aralez Receives Health Canada Approval For BLEXTEN(TM)
Biopharmaceuticals
Regulatory
HSMN NewsFeed - 14 Jan 2008
Inspire Announces Its Termination of Bilastine Licensing Agreement
Biopharmaceuticals
Licensing
HSMN NewsFeed - 20 Jun 2007
Inspire and FAES Farma Amend Bilastine Licensing Agreement
Biopharmaceuticals
Licensing
HSMN NewsFeed - 20 Feb 2007
Inspire Announces Executive Management Promotions
Biopharmaceuticals
Personnel
HSMN NewsFeed - 1 Nov 2006
Inspire and FAES Farma Announce Licensing Agreement for New Oral Antihistamine to Target Allergy Market in United States and Canada
Biopharmaceuticals
LIcensing
Return to NewsFeed
